Saturday, October 11, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyzing Viper Energys Short Interest A Key Indicator of Market Sentiment

Elaine Mendonca by Elaine Mendonca
March 14, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Market sentiment towards Viper Energy (NYSE: VNOM) has shifted recently, with a noticeable decrease in short interest. The short percent of float has dropped by 6.83% since the last report, now standing at 4.5% of all regular shares available for trading. This equates to 2.95 million shares sold short, with traders having an average of 6.08 days to cover their positions.

Understanding short interest is key in gauging investor sentiment towards a stock. A rise in short interest typically indicates bearishness, while a decline may suggest bullishness. While a decrease in Viper Energy’s short interest doesn’t guarantee an immediate stock price increase, it does imply a reduction in shorted shares.

Analysts and investors often use peer comparison to evaluate a company’s performance relative to its industry counterparts. By comparing Viper Energy’s short interest with other companies in the utilities sector, valuable insights into market dynamics and investor sentiment can be gained.

For more in-depth analysis and comparisons regarding Viper Energy’s short interest and stock performance, financial platforms like Fintel, Nasdaq, Benzinga, Barron’s, and MarketBeat can provide additional information.

VNOM Stock Price Rises by 0.81% on March 14, 2024, Showing Strong Performance

On March 14, 2024, VNOM stock experienced a positive trading day, with the price of shares increasing by $0.29 since the previous market close. This represents a 0.81% rise in the stock price, showing a strong performance for the day.

VNOM is currently trading near the top of its 52-week range and is also trading above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time and is exhibiting positive momentum in its price movement.

Overall, the performance of VNOM stock on March 14, 2024, reflects a positive trend in the stock’s price movement. Investors may be optimistic about the company’s prospects, leading to increased buying activity and driving the stock price higher. It will be interesting to see if this positive momentum continues in the coming days and weeks.

VNOM Stock Performance Analysis: Mixed Results with Growth in Net Income and EPS

On March 14, 2024, VNOM stock had mixed performances based on the latest financial data provided by CNN Money.

Total revenue for VNOM stood at $717.11 million for the past year, showing a decrease of 14.42% compared to the previous year. However, the total revenue remained flat at $202.21 million for the last quarter.

Net income for VNOM was reported at $199.79 million for the past year, marking a 31.41% increase compared to the previous year. Similar to the total revenue, the net income held flat at $56.94 million for the last quarter.

Earnings per share (EPS) for VNOM were $2.69 for the past year, showing a 34.72% increase compared to the previous year. The EPS remained flat at $0.70 for the last quarter.

Overall, the financial data for VNOM on March 14, 2024, shows a mixed performance with improvements in net income and earnings per share over the past year, while total revenue has seen a decline. Investors will be closely monitoring the company’s future financial reports to assess its growth prospects and potential for further improvements in its financial performance.

Tags: VNOM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Business travel

The Future of Business Travel: Exploring Innovative Rewards Programs

Biotechnology Trading online

Analyst Upgrades UiPath to Sector Perform Rating with Increased Price Target

Exploring the Rise of NFT Projects: How Cultural Themes Are Reshaping the Crypto Landscape

Recommended

ProShares Bitcoin Strategy ETF Stock

ProShares Bitcoin ETF Demonstrates Resilience Amid Market Volatility

2 weeks ago
Technology Data analytics stock Trading

Chief Visionary Officer of Pure Storage Exercises Stock Options Worth Nearly 17 Million

2 years ago

AMETEK Inc Announces Impressive Increase in Quarterly Dividend

2 years ago
Palantir Stock

Security Concerns Rattle Palantir Investors Following Military Report

2 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

ImageneBio Charts New Course Following Merger Completion

Method Electronics: A Stock at a Critical Crossroads

Abeona Therapeutics Stock Shows Signs of Recovery After Key Commercial Progress

Acquisition Finalized: Faro Shareholders Approve AMETEK’s Premium Buyout

Zumiez Stock: A Valuation Disconnected from Reality

A Potential Turning Point for Thyssenkrupp’s Steel Division

Trending

Alphabet Stock
Analysis

Regulatory Pressure Mounts on Alphabet as UK Designates Search Dominance

by Dieter Jaworski
October 11, 2025
0

Alphabet Inc., the parent company of Google, faces significant regulatory headwinds following a landmark decision by Britain's...

Broadcom Stock

Broadcom Shares Face Pressure After AI-Driven Rally

October 11, 2025
Ocugen Stock

Ocugen Receives Key FDA Clearance to Advance Eye Disease Treatment

October 11, 2025
Ikena Oncology Stock

ImageneBio Charts New Course Following Merger Completion

October 11, 2025
Methode Electronics Stock

Method Electronics: A Stock at a Critical Crossroads

October 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Pressure Mounts on Alphabet as UK Designates Search Dominance
  • Broadcom Shares Face Pressure After AI-Driven Rally
  • Ocugen Receives Key FDA Clearance to Advance Eye Disease Treatment

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com